Psychedelic Therapeutics Market Latest Trends Analysis Report 2024 - InsightAce Analytic
MYCOF Stock | USD 0 0 44.00% |
Roughly 56% of Mydecine Innovations' investor base is looking to short. The analysis of overall sentiment of trading Mydecine Innovations Group pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Mydecine Innovations' historical and current headlines, can help investors time the market. In addition, many technical investors use Mydecine Innovations stock news signals to limit their universe of possible portfolio assets.
Mydecine Innovations pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Mydecine daily returns and investor perception about the current price of Mydecine Innovations Group as well as its diversification or hedging effects on your existing portfolios.
Mydecine |
Psychedelic Therapeutics Market Latest Trends Analysis Report 2024 InsightAce Analytic
Read at news.google.com
Mydecine Innovations Fundamental Analysis
We analyze Mydecine Innovations' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mydecine Innovations using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mydecine Innovations based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Mydecine Innovations is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Peers
Trending Equities
Complementary Tools for Mydecine Pink Sheet analysis
When running Mydecine Innovations' price analysis, check to measure Mydecine Innovations' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mydecine Innovations is operating at the current time. Most of Mydecine Innovations' value examination focuses on studying past and present price action to predict the probability of Mydecine Innovations' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mydecine Innovations' price. Additionally, you may evaluate how the addition of Mydecine Innovations to your portfolios can decrease your overall portfolio volatility.
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Transaction History View history of all your transactions and understand their impact on performance | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
CEOs Directory Screen CEOs from public companies around the world |